In vivo and in vitro antitumor activity of doxorubicin-loaded magnetic fluids

Physica Status Solidi (C) Current Topics in Solid State Physics

Volumn 4, Issue 12, 2007, Pages 4345-4351

  Park, S I ^a   Lim, J H ^a   Hwang, Y H ^a   Kim, K H ^b   Kim, S M ^b   Kim, J H ^a   Kim, C G ^a   Kim, C O ^a  

^a Chungnam National University   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUMOR ACTIVITY; DOXORUBICIN; DRUG RELEASED FRACTION; MAGNETIC PARTICLES;

ADDITION REACTIONS; BIOACTIVITY; BIOSYNTHESIS; DRUG DELIVERY; TUMORS;

MAGNETIC FLUIDS;

EID: 38349140938     PISSN: 18626351     EISSN: None     Source Type: Journal    
DOI: 10.1002/pssc.200777126     Document Type: Conference Paper

References (15)

1. Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, J. Phys. D 36, R167 (2003).
2. R. Dunkan, S. Dimitoijevic, and E. G. Evagaron, STP Pharma. Sci. 6, 237 (1996).
3. P. Vichi and T. R. Triton, Cancer Res. 52, 4135 (1992).
4. T. R. Triton and G. Yee, Science 217, 248 (1982).
5. P. Couvreur, B. Kante, L. Grislain et al., J. Pharm. Sci. 71, 790 (1982).
6. R. B. Weiss, Semin. Oncol. 19, 670 (1992).
7. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni, Pharmacol. Rev. 56, 185 (2004).
8. P. K. Singal, N. Iliskovic, T. Li, and D. Kumar, FASEB J. 11, 931 (1997).
9. M. S. Horenstein, R. S. Van der Heide, and T. J. L'Ecuyer, Mol. Genet. Metab. 71, 436 (2000).
10. T. Hyeon, S. Lee, J. Park, Y. Chung, and H. B. Na, J. Am. Chem. Soc. 123, 12798 (2001).
11. S. I. Park, C. O. Kim, J. H. Kim, S. M. Kim, and K. H. Kim, J. Kor. Mag. Soc. 16(6), 293 (2006).
12. H. D. Han, A. Lee, C. K. Song et al., Int. J. Pharm. 313, 181 (2006).
13. C. C. Berry and A. S. G. Curtis, J. Phys. D 36, R198 (2003).
14. Z. Liu, R. Cheung, X. Y. Wu et al., J. Control Rel. 77, 213 (2001).
15. O. Mykhaylyk, A. Cherchenko, A. Ilkin et al., J. Magn. Magn. Mater. 225, 241 (2001).